NObreath® FeNO device

Fractional exhaled nitric oxide (FeNO) measurement system for non-invasive assessment of airway inflammation. Utilized in diagnosis and monitoring of asthma, COPD, and chronic respiratory conditions with high-precision sensing technology.

A breath analysis diagnostic system for measuring fractional exhaled nitric oxide levels, used to assess airway inflammation in respiratory diseases such as asthma. The platform integrates proprietary smart chip, smart algorithm, and smart manufacturing technologies for clinical and home-based testing.

Portable breath analyzer for measuring fractional exhaled nitric oxide (FeNO) levels, used in clinical assessment of airway inflammation and asthma management. The device provides rapid, non-invasive diagnostic testing suitable for point-of-care and home-based monitoring applications.

Fenobreath is a diagnostic test device for monitoring respiratory function and airway health. It measures exhaled nitric oxide (FeNO) levels to aid in asthma diagnosis, assessment, and management. The device provides rapid, non-invasive testing suitable for clinical and point-of-care settings.

Non-invasive point-of-care assessment device for airway inflammation that combines high-sensitivity biosensor technology (0.1 ppb) with full ATS/ERS compliance. It delivers multi-parameter results including FeNO, CaNO, and FnNO in under one minute, with a patented dual-channel design that ensures complete protection against cross-contamination.

Primary care-based exhaled nitric oxide (FeNO) detection system for guiding drug selection assessment and evaluating therapeutic efficacy. Enables combined or self-testing of exhaled nitrogen oxide to assess airway inflammation and dysbiosis markers in grassroots medical settings.

Home-use exhaled nitric oxide (FeNO) self-testing device for patients to monitor treatment compliance and acute exacerbations. Designed for patients to perform self-testing of exhaled nitrogen oxide to track airway inflammation status at home.

The WLD801 is a non-invasive analyzer that measures exhaled nitric oxide (FeNO) levels to assess airway inflammation in respiratory conditions such as asthma and allergic rhinitis. It provides rapid, objective diagnostic support for clinicians in pulmonology and allergy departments. The device delivers quantitative results with high sensitivity and specificity for patient management.

Home-use exhaled nitric oxide (FeNO) self-testing device for patients to monitor treatment compliance and acute exacerbations. Designed for patients to perform self-testing of exhaled nitrogen oxide to track airway inflammation status at home.

Hospital-based exhaled nitric oxide (FeNO) detection system designed for patients with complications and critical illnesses. Enables multi-molecular, multi-airway exhaled gas combined testing to assess airway inflammation and dysbiosis markers for respiratory system disease precision medicine.

Hospital-based exhaled nitric oxide (FeNO) detection system designed for patients with complications and critical illnesses. Enables multi-molecular, multi-airway exhaled gas combined testing to assess airway inflammation and dysbiosis markers for respiratory system disease precision medicine.

A home-use breath analyzer designed for patients with chronic respiratory diseases and susceptible populations, featuring a mobile application and detection diagnostic treatment service card. It offers FeNO/FnNO self-testing capabilities using hospital-grade gas detection technology with interconnected diagnostic services, enabling chronic respiratory disease patients to reduce acute exacerbations and emergency hospitalization, and susceptible populations to reduce disease development risk.